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Abstract
Objective:  To  study  the  demographic  proﬁle,  prognostic  indicators,  and  mortality
of  tetanus  patients  and  treatment  outcomes  following  intramuscular  anti-tetanus
immunoglobulin  (ATG)  alone  or  combined  intrathecal  and  intramuscular  ATG.
Design:  Retrospective  study.
Setting:  Inpatients  from  a  tertiary  care  hospital.
Subjects:  One  hundred  children  under  12  years  of  age  diagnosed  with  tetanus  and
admitted  from  January  2003  to  December  2007  were  included  in  the  study.
Methods:  Case  records  of  patients  with  neonatal  tetanus  (n  =  30)  and  post-neonatal
tetanus  (n  =  70)  were  evaluated  retrospectively.  The  diagnosis  of  tetanus  was  based
on  World  Health  Organization  (WHO)  criteria.  The  outcomes  of  patients  treated  with
either  intramuscular  ATG  or  both  intrathecal  and  intramuscular  ATG  were  separately
compared  in  the  neonatal  and  post-neonatal  groups.
Results:  Our  study  revealed  difﬁculty  in  feeding,  trismus,  spasms,  rigidity,  and
opisthotonus  posturing  as  the  predominant  clinical  manifestations.  The  survival  rate
for  children  receiving  tetanus  immunoglobulin  by  the  dual  route  was  signiﬁcantly
higher  than  for  children  receiving  the  immunoglobulin  via  the  intramuscular  route.
Seizures  and  tremors  were  poor  prognostic  factors  associated  with  tetanus.
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ntroductionetanus  is  one  of  the  most  deadly  diseases.  It
ontinues to  cause  approximately  213,000—293,000
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ttp://dx.doi.org/10.1016/j.jiph.2013.07.006eaths  worldwide  each  year,  180,000  of  which  have
een reported  in  neonates  [1,2].  In  India,  tetanus
s endemic  and  remains  an  important  health  prob-
em. The  annual  incidence  of  neonatal  tetanus
s 1.74/1000  live  births  [3]. The  exact  incidence
f non-neonatal  tetanus  in  India  is not  known.
etanus is  the  only  vaccine-preventable  disease
hat is  not  communicable;  rather,  it  is  acquired
hrough environmental  exposure  to  the  spores  of
 Sciences. Published by Elsevier Ltd. All rights reserved.
c
c
t
a
s
t
a
m
o
A
S
a
t
R
R
m
(
w
a
m
t
c
t
u
c
1
e
7
h
l
(
(
[
p
t
(
r
a
c
r
a
p
t
d
w
(
u122  
the  bacterium  Clostridium  tetani.  The  incidence  of
the disease  has  been  decreasing  in the  developed
world, mainly  due  to  effective  immunization  pro-
grams [1,2].  Presently,  neonatal  tetanus  has  been
eliminated  in  15  states  and  union  territories  in
India [4].  Still,  the  complete  eradication  of  neona-
tal tetanus  is  still  a  long  way  away.  With  increasing
immunization  coverage,  the  chances  of  eliminating
tetanus have  increased  greatly.  However,  literature
pertaining  to  the  epidemiology  of  tetanus  in  Delhi  is
limited. Our  study  was  designed  to  study  the  demo-
graphic  proﬁle,  prognostic  indicators,  and  mortality
of tetanus  and  the  treatment  outcomes  following
intramuscular anti-tetanus  immunoglobulin  (ATG)
alone or  combined  intrathecal  and  intramuscular
ATG over  a  5-year  period.
Methodology
This  retrospective,  descriptive  study  was  con-
ducted  in  the  pediatric  department  of  a  tertiary
care hospital  of  East  Delhi  over  a  5-year  period
between 1  January  2003  and  31  December  2007.
Clearance was  obtained  from  an  institutional  ethics
committee.  The  study  conformed  to  local  regu-
lation, Good  Clinical  Practices  (GCP),  applicable
International Conference  on  Harmonization  (ICH)
guidelines,  and  the  ethical  principles  of  the  Dec-
laration  of  Helsinki.
The  case  records  of  100  consecutive  patients
diagnosed with  tetanus  who  were  admitted  to
our hospital  during  this  period  and  met  the  World
Health  Organization  (WHO)  case  deﬁnition  of
tetanus were  reviewed  to  gather  information
regarding  demographic  and  clinical  data,  giving
a mean  of  20  cases  per  annum.  Thirty  cases  of
tetanus occurred  in  the  neonatal  age  group,  and
70 cases  were  post-neonatal  tetanus.  A  case  of
neonatal  tetanus  was  deﬁned  as  one  that  had
the following  signs  and  symptoms  occurring  in
sequence:  history  of  normal  suck  and  cry  for  the
ﬁrst 2 days  of  life,  history  of  onset  of  illness
between 3  and  28  days  of  age  with  inability  to
suck, stiffness,  and/or  convulsions.  The  diagnosis
of post-neonatal  tetanus  was  based  on  clinical
features (i.e.,  presence  of  trismus,  risus  sardon-
icus, and/or  provoked  or  unprovoked  spasms).
A structured  proforma  was  used  to  record  infor-
mation. A  brief  history  pertaining  to  maternal
details of  gestational  age  [as  per  last  menstrual
period (LMP)],  mode  of  delivery,  and  delivery
by an  unskilled  health  professional  was  obtained
for neonatal  tetanus.  Birth  details  regarding
immunization,  portal  of  entry,  incubation  period,
period of  onset,  clinical  features,  treatment,
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omplications,  and  outcomes  were  recorded  in  the
ase record  form.  Outcomes  were  based  on  whether
he patient  survived  or  expired.  Patients  who  left
gainst medical  advice  were  excluded  from  the
tudy. The  objective  of  the  study  was  to  determine
he demographic  proﬁles,  prognostic  indicators,
nd mortality  of  tetanus  patients,  along  with  treat-
ent outcomes  following  intramuscular  ATG  alone
r combined  intrathecal  and  intramuscular  ATG.
The data  were  analyzed  using  SPSS  version  13.
ll quantitative  variables  were  compared  using
tudent’s  t-test,  and  categorical  variables  were
nalyzed  using  the  Chi-square  test  or  Fisher’s  exact
est. P  <  0.05  was  considered  signiﬁcant.
esults
ecords  of  30  cases  of  neonatal  tetanus  [20  (66%)
ales] and  70  cases  of  post-neonatal  tetanus  [44
62.8%) males]  were  retrieved.  Mortality  outcomes
ere observed  in  10  (33%)  cases  of  neonatal  tetanus
nd 9 (12.8%)  cases  of  post-neonatal  tetanus.  The
edian age  of  presentation  was  5.6  days  in  neonatal
etanus.  Risk  factors  were  identiﬁable  in  28  (93.3%)
ases of  neonatal  tetanus.  The  possible  risk  fac-
ors included  unimmunized  mothers,  22  (73.3%);
nsterilized material  used  to  cut  the  umbilical
ord, 16  (53.3%);  substance  placed  on  the  cord,
6 (53.3%);  home  delivery,  25  (83.3%);  and  deliv-
ry by  an  untrained  professional,  26  (86.6%).  Among
0 patients  with  post-neonatal  tetanus,  64  (91.4%)
ad an  identiﬁable  acute  injury  (puncture  wound  or
aceration [22  (31.4%)]  and  ear  discharge  [42  (60%)].
Clinical presentations  in  neonatal  tetanus
n =  30)  included  trismus  [30  (100%)],  spasms  [29
96.6%)], rigidity  [25  (83.3%)],  refusal  to  feed
13 (43.3%)],  and  tremors  [10  (33.3%)].  Similarly,
resentations in  the  post-neonatal  group  included
rismus  [65  (92.8%)],  difﬁculty  in  feeding  [55
78.6%)],  opisthotonus  posturing  [51  (72.8%)],
isus sardonicus  [36  (51.4%)],  seizures  [8  (11.4%)],
nd unconsciousness  [63  (90%)].  Among  the  30
ases of  neonatal  tetanus,  13  (43.3%)  patients
eceived the  entire  dose  of  human  ATG  (500  IU)
s an  intramuscular  injection,  whereas  17  (56.6%)
atients  received  50%  of  the  human  ATG  dose  via
he intrathecal  route  and  the  other  50%  of  the
ose via  the  intramuscular  route.  Among  children
ith  post-neonatal  tetanus  (n  =  70),  5  children
7.1%) required  mechanical  ventilation,  22  (31.4%)
nderwent  wound  debridement,  28  (40%)  received
he entire  dose  of  ATG  via  the  intramuscular  route,
nd the  other  42  (60%)  received  half  of  the  dose
ia the  intramuscular  route  and  the  other  half  of
he dose  via  the  intrathecal  route.  We  observed
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Table  1  Table  comparing  the  outcomes  of  ATG  administration  via  the  intramuscular  route  alone  and  via  both  the
intramuscular  and  intrathecal  routes  in  neonatal  and  post-neonatal  tetanus.
Outcome  Intramuscular  alone  Both  intramuscular  and  intrathecal  P  value
Neonatal  tetanus  (n  =  30)
Survivor  (n  =  20)  5  (38.5%)  15  (88.2%)
0.002Non  survivor  (n  =  10)  8  (61.5%)  2  (11.8%)
Post-neonatal  tetanus  (n  =  70)
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aSurvivor  (n  =  61) 21  (75%)  
Non  survivor  (n  =  9) 7  (25%)
hat  mortality  was  higher  in  children  who  received
TG via  the  intramuscular  route  alone  for  both
eonatal tetanus  (P  =  0.002)  and  post-neonatal
etanus (P  =  0.025)  (Table  1).
iscussion
he  global  efforts  for  neonatal  tetanus  elimination
ave resulted  in  157  countries  with  less  than  1  case
f neonatal  tetanus  per  1000  live  births  per  district,
ut neonatal  tetanus  elimination  remains  a  major
roblem  in  57  countries,  including  India  [1,2].
ach case  of  neonatal  or  post-neonatal  tetanus
epresents the  failure  of  the  health  services  to
rovide  not  only  routine  immunizations  but  also
outine antenatal  and  postnatal  care.  WHO,  the
nited  Nations  Children’s  Fund  (UNICEF),  and  the
nited  Nations  Population  Fund  (UNFPA)  advocate
he ‘‘high-risk  approach’’  to  eliminate  neonatal
etanus, which  involves  identifying  districts  at  high-
st risk  within  countries  and  focusing  interventions
n those  areas.  Our  study  was  designed  to  study  the
emographic  proﬁles,  prognostic  indicators,  and
redictors  of  tetanus-related  mortality  over  a 5-
ear period.
Our  study  implicated  difﬁculty  in  feeding,  tris-
us, spasms,  rigidity,  and  opisthotonus  posturing
s the  predominant  clinical  manifestations  in  the
eonatal  group.  In  the  post-neonatal  age  group,  ear
ischarge was  present  in  60%  of  patients,  and  his-
ory of acute  injury  was  noted  in  31%  of  patients.
n a  study  conducted  in  Malaysia  predominantly
nvolving  patients  in  older  age  groups  who  were
iagnosed with  tetanus  over  a  10-year  duration,
ody stiffness,  trismus,  and  dysphagia  were  the
hree most  common  manifestations  of  tetanus.
early 81%  patients  had  an  identiﬁable  history  of
cute injury  [5].
We  noted  that  the  survival  rates  in  children
eceiving tetanus  immunoglobulin  via  the  dual
oute  were  signiﬁcantly  higher  than  the  rates
or children  who  received  the  immunoglobulin
nly intramuscularly.  Although  standard  textbooks
o not  currently  recommend  intrathecal  ATG
t
w
p40  (95.3%)
0.0252  (4.7%)
dministration,  studies  have  demonstrated  that  the
ntrathecal route  of  ATG  administration  is  superior
o the  intravenous  and  intramuscular  routes  [6,7].
irect administration  of  intrathecal  ATG  would  bind
aster to  the  toxins  released  by  C.  tetani  in  cen-
ral nervous  system  as  compared  to  ATG  injected  by
ther routes.  A  potential  limitation  of  this  study  is
hat it  is  a retrospective  study.  However,  the  results
f the  study  prompt  us  to  conduct  a  prospective
tudy. A  study  conducted  in  Brazil  with  over  120  sub-
ects showed  better  clinical  progression  (P  =  0.005)
n patients  who  received  ATG  via  the  combined
ntrathecal and  intramuscular  route  compared  to
he intramuscular  route  alone  [6]. The  durations  of
pasm occurrences,  hospital  stays,  and  respiratory
ssistance were  also  short.  Another  meta-analysis
f 12  trials  conducted  with  over  942  patients
eported the  combined  risk  ratio  of  mortality  for
he intrathecal  versus  the  intramuscular  route  to
e 0.71,  thus  implicating  intrathecal  therapy  as
ore beneﬁcial  [7]. The  only  advantage  of  the
ntramuscular  route  is  easy  administration,  whereas
ntrathecal  administration  requires  skilled  staff.
Further, our  study  has  shown  seizures  and
remors to  be  poor  prognostic  factors  in  the  post-
eonatal  and  neonatal  age  groups,  respectively.
 study  conducted  in  Ethiopia  indicated  that  the
on-neonatal  age  group  was  associated  with  poor
utcome  in  patients  with  an  onset  of  48  h  or  less
nd in  patients  presenting  within  72  h  of  onset  [8].
n the  neonatal  age  group,  an  onset  of  48  h or  less,
n incubation  period  of  less  than  7  days,  tachy-
ardia [heart  rate  (HR)  >  140  beats/min],  and  the
resence  of  fever  were  associated  with  poor  out-
omes.  A  retrospective  study  analyzed  55  cases  of
eonatal  tetanus  over  a 5-year  duration  and  noted
hat the  poor  prognostic  factors  were  lower  birth
eight,  younger  age  at  symptom  onset  and  at  the
ime of  admission,  and  the  presence  of  opisthotonus
nd risus  sardonicus  [9].
This study  summarizes  increased  mortality  in
he neonatal  period.  Non-immunization  of  mothers
ith tetanus  toxoid,  delivery  by  an  untrained  health
rofessional,  and  the  use  of  unsterilized  material
EN
R
[
[
[
[
[
[
[
[124  
on  the  umbilical  cord  are  the  main  risk  factors  for
the occurrence  of  neonatal  tetanus.  This  study  fur-
ther adds  that  a  combination  of  intramuscular  and
intrathecal  tetanus  immunoglobulin  administration
serves as  a  better  modality  for  reducing  mortality
in neonatal  and  post-neonatal  tetanus.
Conclusion
To  conclude,  a  combination  of  intrathecal  and  intra-
muscular  anti-tetanus  immunoglobulin  is  a superior
modality  to  intramuscular  administration  alone
in reducing  the  mortality  of  tetanus  in  any  age
group.
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